Edge Pharma Phenylephrine HCl IV Injection Sterility Assurance Recall
Edge Pharma is recalling Phenylephrine HCl 1mg/10mL single-use syringes for IV injection due to lack of assurance of sterility. The recall affects 6,535 vials distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall involving lack of sterility assurance in an IV injection product. Class II recalls with risk of serious adverse health consequences in injectable drugs warrant a Severe classification per the rubric.
Plain-English summary
Edge Pharma, LLC is recalling Phenylephrine HCl, 1mg/10mL (0.1mg/mL), 10 mL per syringe, Single Use Syringe for IV Injection, manufactured by Edge Pharma, LLC at 856 Hercules Dr, Colchester, VT 05446 (NDC 05446-1544-10). The recall affects 6,535 vials distributed nationwide.
The reason for recall is a lack of assurance of sterility. Affected lot codes are 08-2021-26@3 (dated 12/16/2021), 09-2021-16@5 (dated 12/29/2021), 10-2021-07@2 (dated 01/19/2022), and 10-2021-22@1 (dated 02/03/2022).
Patients and healthcare providers who have received or are using this product should discontinue use and contact Edge Pharma, LLC or the FDA for further guidance. The FDA has classified this as a Class II recall.
The recalled product
- Product
- Phenylephrine HCl, 1mg/10mL (0.1mg/mL), 10 mL per syringe, Single Use Syringe for IV Injection, Edge Pharma, LLC, 856 Hercules Dr, Colchester, VT 05446 NDC 05446-1544-10
- Manufacturer
- Edge Pharma, LLC
- Hazard
- sterility-assurance
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- 08-2021-26@3 12/16/2021
- 09-2021-16@5 12/29/2021
- 10-2021-07@2 01/19/2022 & 10-2021-22@1 02/03/2022.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27